Bradykinin B 1 Receptor Mediates Inhibition of Neointima Formation in Rat Artery After Balloon Angioplasty
Open Access
- 1 September 2000
- journal article
- other
- Published by Wolters Kluwer Health in Hypertension
- Vol. 36 (3) , 364-370
- https://doi.org/10.1161/01.hyp.36.3.364
Abstract
—We evaluated the effects of the kallikrein-kinin system on the proliferation and migration of primary cultured vascular smooth muscle cells (VSMCs) in vitro and neointima formation in balloon-injured rat carotid arteries in vivo. In cultured rat VSMCs, tissue kallikrein inhibited cell proliferation, and this inhibitory effect was blocked by Sar-Tyr-Aca(ε)-Lys [ d -βNal 7 ,Ile 8 ]-des-Arg 9 -bradykinin, a bradykinin B 1 receptor antagonist, and by icatibant, a bradykinin B 2 receptor antagonist. Platelet-derived growth factor significantly increased the expression of the B 1 receptor but not the B 2 receptor in VSMCs. Platelet-derived growth factor–induced cell migration was significantly attenuated by des-Arg 9 -bradykinin and to a lesser degree by bradykinin. Endogenous B 1 receptor mRNA increased in rat carotid arteries after balloon angioplasty. After local delivery of adenovirus carrying the human tissue kallikrein gene into the rat carotid artery, we observed a 54% reduction in the intima/media ratio at the injured site compared with the control ratio (n=7, P 1 receptor antagonist via minipumps blocked the protective effect of kallikrein and partially reversed the intima/media ratio toward the control ratio. Kallikrein gene delivery results in the regeneration of endothelium compared with the control groups, and the B 1 receptor antagonist abolished this effect. Nitrite/nitrate, cGMP, and cAMP levels in balloon-injured arteries significantly increased after kallikrein gene delivery, whereas the B 1 receptor antagonist abolished these increases (n=4 or 5, P 1 receptor contributes to the reduction of neointima formation via the promotion of reendothelialization and inhibition of VSMC proliferation and migration through NO-cGMP and cAMP signaling pathways. This study provides significant implications in treating restenosis after revascularization.Keywords
This publication has 32 references indexed in Scilit:
- B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF‐2 effectsBritish Journal of Pharmacology, 1998
- Does Nitric Oxide Regulate Smooth Muscle Cell Proliferation?Journal of Vascular Research, 1998
- Human Kallikrein Gene Delivery Attenuates Hypertension, Cardiac Hypertrophy, and Renal Injury in Dahl Salt-Sensitive RatsHuman Gene Therapy, 1998
- Expression of platelet-derived growth factor B-chain in neointimal smooth muscle cells of balloon injured rabbit femoral arteriesAtherosclerosis, 1996
- Proteases involved in the metabolism of angiotensin II, bradykinin, calcitonin gene-related peptide (CGRP), and neuropeptide Y by vascular smooth muscle cellsPeptides, 1996
- Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury.The Journal of Experimental Medicine, 1994
- Bradykinin B1 receptors in rabbit aorta smooth muscle cells in cultureEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Angiotensin Converting Enzyme Inhibitors or DuP753 Prevent Neointimal Formation Following Balloon Injury with Single Topical or Multiple Systemic ApplicationBiochemical and Biophysical Research Communications, 1993
- Rat aortic smooth muscle cells in culture express kallikrein, kininogen, and bradykininase activity.Journal of Clinical Investigation, 1990
- Analysis of angiotensin‐stimulated sodium transport in cultured smooth muscle cells from rat aortaJournal of Cellular Physiology, 1983